Clinical meaning
Osteoporosis is a systemic skeletal disorder characterized by low bone mineral density (BMD) and microarchitectural deterioration of bone tissue, leading to increased fragility and fracture risk. Bone is a dynamic tissue maintained by the continuous, coupled process of bone remodeling: osteoclasts resorb old or damaged bone, creating resorption lacunae (Howship lacunae), and osteoblasts subsequently fill these cavities with new osteoid that mineralizes into mature lamellar bone. This remodeling cycle takes approximately 4-6 months to complete and occurs at over one million sites simultaneously throughout the skeleton. The balance between resorption and formation is regulated by the RANK/RANKL/OPG axis. Osteoblasts produce RANK ligand (RANKL), which binds to RANK receptors on osteoclast precursors, stimulating their differentiation into mature, active osteoclasts. Osteoblasts also produce osteoprotegerin (OPG), a decoy receptor that binds RANKL and prevents osteoclast activation. The RANKL-to-OPG ratio determines net bone resorption or formation. Estrogen is a critical regulator of this balance: it stimulates OPG production by osteoblasts and suppresses osteoclast-activating cytokines (IL-1, IL-6, TNF-alpha). After menopause, the precipitous decline in estrogen dramatically increases the RANKL:OPG ratio, unleashing osteoclast activity and causing...